IndraLab

Statements

KCNH2 inhibits antagonist. 1 / 1

| 1

sparser

"The in vitro ADMET properties —microsomal metabolism, CYP2D6 inhibition, HSA binding, cell permeability, and hERG inhibition— of the 5-HT 6 R antagonist newly identified herein 7 excluded important pharmacokinetic issues and possible lethal side effects related with cardiac toxicity (see Results section)."

28117458

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

KCNH2 inhibits antagonist. 1 / 1

INDRA sources:

Databases

Reading